Necrostatin-1 as a Neurogenic Agent to Ameliorate the Neurogenesis and Motor Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy Through RIP1 Inhibition: A Research Protocol
Posted on 2025-11-05
A new article from the URNCST Journal has been published! Read more about it here:
